Uveitis and Other Ocular Complications Following COVID-19 Vaccination.
COVID-19
SARS-CoV-2 disease
ocular complications
uveitis
vaccination
vaccine
vaccine-associated uveitis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
19 Dec 2021
19 Dec 2021
Historique:
received:
19
11
2021
revised:
07
12
2021
accepted:
17
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) vaccines can cause transient local and systemic post-vaccination reactions. The aim of this study was to report uveitis and other ocular complications following COVID-19 vaccination. The study included 42 eyes of 34 patients (20 females, 14 males), with a mean age of 49.8 years (range 18-83 years). The cases reported were three herpetic keratitis, two anterior scleritis, five anterior uveitis (AU), three toxoplasma retinochoroiditis, two Vogt-Koyanagi-Harada (VKH) disease reactivations, two pars planitis, two retinal vasculitis, one bilateral panuveitis in new-onset Behçet's disease, three multiple evanescent white dot syndromes (MEWDS), one acute macular neuroretinopathy (AMN), five retinal vein occlusions (RVO), one non-arteritic ischemic optic neuropathy (NAION), three activations of quiescent choroidal neovascularization (CNV) secondary to myopia or uveitis, and one central serous chorioretinopathy (CSCR). Mean time between vaccination and ocular complication onset was 9.4 days (range 1-30 days). Twenty-three cases occurred after Pfizer-BioNTech vaccination (BNT162b2 mRNA), 7 after Oxford-AstraZeneca vaccine (ChAdOx1 nCoV-19), 3 after ModernaTX vaccination (mRNA-1273), and 1 after Janssen Johnson & Johnson vaccine (Ad26.COV2). Uveitis and other ocular complications may develop after the administration of COVID-19 vaccine.
Identifiants
pubmed: 34945256
pii: jcm10245960
doi: 10.3390/jcm10245960
pmc: PMC8704915
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cureus. 2020 Dec 7;12(12):e11950
pubmed: 33425529
Int J Dermatol. 2020 Aug;59(8):1028-1029
pubmed: 32530063
Int J Infect Dis. 2021 Sep;110:95-97
pubmed: 34289406
J Ophthalmic Inflamm Infect. 2021 Jul 5;11(1):21
pubmed: 34224024
Ocul Immunol Inflamm. 2019;27(4):517-520
pubmed: 31247152
Lancet Infect Dis. 2021 Jan;21(1):39-51
pubmed: 33069281
Lancet Haematol. 2020 Jun;7(6):e425
pubmed: 32470428
Vaccines (Basel). 2021 Nov 17;9(11):
pubmed: 34835280
BMJ Case Rep. 2021 Jul 19;14(7):
pubmed: 34281937
JAAD Case Rep. 2021 Jun;12:58-59
pubmed: 33937467
JAMA Ophthalmol. 2021 Jul 1;139(7):e212471
pubmed: 34287612
J Cosmet Dermatol. 2021 Jun;20(6):1566-1567
pubmed: 33638924
Ocul Immunol Inflamm. 2021 May 19;29(4):753-757
pubmed: 34344280
Acta Ophthalmol. 2020 Dec;98(8):e1056-e1057
pubmed: 32483943
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
J Ophthalmic Inflamm Infect. 2021 Sep 17;11(1):33
pubmed: 34533628
Indian J Ophthalmol. 2021 Oct;69(10):2865-2866
pubmed: 34571653
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
J Fr Ophtalmol. 2022 Sep;45(7):e299-e302
pubmed: 35717218
Indian J Ophthalmol. 2021 Mar;69(3):488-509
pubmed: 33595463
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Klin Monbl Augenheilkd. 2022 Sep;239(9):1132-1133
pubmed: 33853180
J Ophthalmic Inflamm Infect. 2021 Sep 16;11(1):28
pubmed: 34529153
Curr Opin Ophthalmol. 2018 Nov;29(6):588-603
pubmed: 30222658
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1216-1224
pubmed: 34559576
Lancet. 2021 May 1;397(10285):e11
pubmed: 33864750
Mediterr J Hematol Infect Dis. 2021 Mar 01;13(1):e2021048
pubmed: 34276917
J Am Acad Dermatol. 2020 Sep;83(3):e257-e259
pubmed: 32585280
Ocul Immunol Inflamm. 2021 May 19;29(4):730-733
pubmed: 34187278
N Engl J Med. 2021 Sep 23;385(13):1172-1183
pubmed: 34192426
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1210
pubmed: 34406890
Mo Med. 2016 Jan-Feb;113(1):48-52
pubmed: 27039491
Eye (Lond). 2020 Dec;34(12):2352-2353
pubmed: 32620843
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
World J Pediatr. 2021 Jun;17(3):329-334
pubmed: 33619650
BMC Ophthalmol. 2021 Jul 13;21(1):276
pubmed: 34256728
Indian J Ophthalmol. 2020 Oct;68(10):2291-2293
pubmed: 32971697
Graefes Arch Clin Exp Ophthalmol. 2020 Sep;258(9):1959-1963
pubmed: 32504100
Eur J Ophthalmol. 2022 Jan;32(1):NP168-NP172
pubmed: 32735134
J Med Virol. 2021 Sep;93(9):5231-5232
pubmed: 33913545
Cornea. 2021 Sep 1;40(9):1204-1206
pubmed: 34351874
Vaccines (Basel). 2021 Sep 11;9(9):
pubmed: 34579250
Curr Clin Microbiol Rep. 2019 Mar;6(1):44-50
pubmed: 31179204
Eye (Lond). 2022 Mar;36(3):644-645
pubmed: 34158652
Retin Cases Brief Rep. 2022 Jan 1;16(1):1-4
pubmed: 31971925
Int Ophthalmol. 2021 Dec;41(12):3889-3892
pubmed: 34426861
Rheumatology (Oxford). 2022 May 5;61(5):e112-e113
pubmed: 34617989
JAMA Ophthalmol. 2021 Oct 1;139(10):1131-1135
pubmed: 34473209
Sci Immunol. 2021 Jun 22;6(60):
pubmed: 34158390
Retina. 2021 Dec 1;41(12):2462-2471
pubmed: 34369440
Am J Ophthalmol Case Rep. 2021 Sep;23:101136
pubmed: 34151047
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Surv Ophthalmol. 2022 Mar-Apr;67(2):293-306
pubmed: 33865883